Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for LVH in Resistant Hypertension and OSA
NCT03186742Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Jul 2014
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of eplerenone in resistant hypertension (RH), left ventricular hypertrophy (LVH), obstructive sleep apnea (OSA), sponsored by Poznan University of Medical Sciences. Started Jul 2014; status: completed.
02
Drugs
eplerenone
03
Conditions
resistant hypertension (RH)left ventricular hypertrophy (LVH)obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03186742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186742.